Skip to main content
Fig. 6 | Cancer Nanotechnology

Fig. 6

From: Nanoliposomal VEGF-R2 peptide vaccine acts as an effective therapeutic vaccine in a murine B16F10 model of melanoma

Fig. 6

Flow cytometric evaluation of TILs in the tumor sites of C57BL/6 mice. Statistical analysis for the percentage of A CD3+ CD8+ TILs, B CD3+ CD4+ TILs, and C CD4+ CD25+ FoxP3+ TILs. The statistical analysis of the data is presented as Mean ± SD with a sample size of n = 3. The level of significance is denoted as * P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 indicating a significant difference between groups

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us